@prefix orcid: <https://orcid.org/> .
@prefix this: <http://purl.org/np/RASNkcrKLqvX45Dk1Bh6CgctB_FNZEGCpn9yoqxZ_pVe0> .
@prefix sub: <http://purl.org/np/RASNkcrKLqvX45Dk1Bh6CgctB_FNZEGCpn9yoqxZ_pVe0#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:3uitj0kw&rows=> .
@prefix ns1: <http://wordnet-rdf.princeton.edu/lemma/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo .
}

sub:assertion {
  <https://uts.nlm.nih.gov/uts/umls/concept/C1705938> ns1:associate <https://uts.nlm.nih.gov/uts/umls/concept/C0030705> .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2021-12-16T20:04:09.145136"^^xsd:dateTime;
    prov:wasGeneratedBy "S&T TWOC project version 2" .
  
  sub:version prov:value "2"^^xsd:integer .
  
  rdf:OBJECT rdfs:label "with good outcomes among select patients with newly diagnosed or stage I / II NK / T-LAHLH" .
  
  rdf:OBJECT-POSITION rdfs:label "31"^^xsd:integer .
  
  rdf:PREDICATE rdfs:label "associated" .
  
  rdf:PREDICATE-POSITION rdfs:label "[229]" .
  
  rdf:SUBJECT rdfs:label "etoposide + dexamethasone-based chemotherapy regimens" .
  
  rdf:SUBJECT-POSITION rdfs:label "196"^^xsd:integer .
  
  rdfs:ABSTRACT-UID ns2:50 "3uitj0kw" .
  
  rdfs:SENTENCE rdfs:label "Although patients with hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy generally experienced poor outcomes, etoposide + dexamethasone-based chemotherapy regimens were associated with good outcomes among select patients with newly diagnosed or stage I/II NK/T-LAHLH." .
  
  rdfs:TRIPLE-UID ns3:3uitj0kw-TRIPLE-ABSTRACT-19 "3uitj0kw-TRIPLE-ABSTRACT-19" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C0030705> rdfs:label "patients" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C1705938> rdfs:label "based" .
}

sub:pubInfo {
  sub:assertion prov:wasDerivedFrom <https://doi.org/10.1007/s00432-020-03376-7> .
  
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
    npx:hasSignature "QkEhcL6U/j3zcdbVtOwWtdduYSn1lBqM/RhY6vpXQw67aIVTUQmBuhM16jRa9DXezMNM6vVf4Xa5ZE+HlJ64j2A07CM78szvnN67lSFJeX1Ex2RPOStsljysf6EyHudy7kx9G0mycpglujZNJZdbVuOXgIvN0gDKwXPRJMK6D7Q=";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2021-12-16T20:04:09.145136"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}